GO:2000316 regulation of T-helper 17 type immune response: Immune Regulation, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:2000316 describes any process that modulates the frequency, rate, or extent of the T-helper 17 (Th17) immune response.
• Th17 cells are a distinct CD4+ T helper subset defined by production of IL-17 and related cytokines, and they are critical for mucosal immunity but also drive autoimmune pathology.
• The balance between Th17 and regulatory T cells (Treg) is a central checkpoint in autoimmune and metabolic diseases.
• Metabolic and epigenetic reprogramming, such as via the glucose transporter GLUT3, directly controls Th17 cell responses.
• MicroRNAs provide an additional layer of post-transcriptional regulation of the Th17/Treg balance in autoimmune disease.
• Dysregulated Th17 responses are implicated in periodontitis, inflammatory bowel disease, and other chronic inflammatory conditions.
Description
The Gene Ontology term GO:2000316, regulation of T-helper 17 type immune response, refers to any biological process that modulates the frequency, rate, or extent of the Th17 immune response. Th17 cells are a subset of CD4+ T helper cells characterized by the production of interleukin-17 (IL-17) and related cytokines, and they play essential roles in host defense against extracellular bacteria and fungi at mucosal barriers. However, excessive or misdirected Th17 activity is a hallmark of several autoimmune and inflammatory disorders, making the regulation of this response a major research focus. Understanding how Th17 responses are controlled at the cellular and molecular level is therefore critical for both basic immunology and therapeutic development. This article integrates authoritative Gene Ontology annotation with published literature to provide a research-grade overview of GO:2000316, its mechanisms, key genes, disease relevance, and experimental approaches.
regulation of T-helper 17 type immune response At A Glance
| GO ID | GO:2000316 |
|---|---|
| GO term | regulation of T-helper 17 type immune response |
| Ontology | biological_process |
| Synonym | regulation of Th17 immune response |
| Definition | Any process that modulates the frequency, rate or extent of T-helper 17 type immune response. |
| Major function | Controls the activation, differentiation, and effector activity of Th17 cells, which produce IL-17 and related cytokines. |
| Related cell type | CD4+ T helper 17 (Th17) cells |
| Key cytokines | IL-17, IL-21, IL-22, IL-23, TGF-beta, IL-6 |
| Physiological role | Mucosal immunity against extracellular pathogens |
| Pathological role | Autoimmune and inflammatory diseases, including periodontitis and colitis |
What Is GO:2000316?
GO:2000316 is defined as any process that modulates the frequency, rate, or extent of the T-helper 17 type immune response. In practical terms, it encompasses all molecular and cellular events that either promote or suppress the activation, differentiation, expansion, contraction, or effector function of Th17 cells. This includes cytokine signaling, transcription factor activity, metabolic reprogramming, epigenetic changes, and microRNA-mediated regulation that collectively determine the magnitude and duration of a Th17 response.
Why Is regulation of T-helper 17 type immune response Important in Cell Biology?
Regulation of the Th17 immune response is critically important because Th17 cells sit at the intersection of protective immunity and autoimmune pathology. While they are essential for defending mucosal surfaces against extracellular bacteria and fungi, their uncontrolled activation contributes to chronic inflammatory diseases such as periodontitis, inflammatory bowel disease, and metabolic disorders. The balance between Th17 and regulatory T cells is a key determinant of immune homeostasis, and its dysregulation is associated with autoimmunity. Therefore, understanding GO:2000316 provides a framework for identifying therapeutic targets and biomarkers in immune-mediated diseases.
• Th17 cells are a major CD4+ T helper subset with distinct cytokine profiles and developmental requirements.
• The Th17/Treg balance is a central checkpoint in autoimmune and metabolic diseases.
• MicroRNAs regulate the Th17/Treg balance and influence autoimmune disease pathogenesis.
• Metabolic reprogramming via GLUT3 controls Th17 cell responses through glycolytic-epigenetic mechanisms.
• Dysregulated Th17 responses are implicated in periodontitis pathogenesis.
• Milk-derived extracellular vesicles can alleviate ulcerative colitis by modulating gut immunity and Th17 responses.
• Th17 cells are targets for biologic therapies in psoriasis, inflammatory bowel disease, and other conditions.
• Understanding Th17 regulation can guide vaccine design and mucosal adjuvant development.
• Th17 responses are linked to immune responses to injury and eye disease.
• Mitophagy and autophagy pathways intersect with immune regulation and autoimmune diseases.
What Happens During regulation of T-helper 17 type immune response?
Th17 cell differentiation and lineage commitment
In simple terms: This is the step where naive T cells are instructed to become Th17 cells.
In the presence of specific cytokines such as TGF-beta, IL-6, IL-21, and IL-23, naive CD4+ T cells differentiate into Th17 cells. This process requires the transcription factor RORgamma-t (RORC) and is influenced by metabolic and epigenetic reprogramming. The differentiation program is tightly regulated to ensure appropriate Th17 responses at mucosal barriers while preventing excessive inflammation.
Cytokine signaling and amplification
In simple terms: Once Th17 cells are formed, they secrete cytokines that recruit and activate more immune cells.
Differentiated Th17 cells produce IL-17A, IL-17F, IL-21, and IL-22, which act on epithelial and stromal cells to induce antimicrobial peptides and pro-inflammatory mediators. IL-23 signaling is critical for the maintenance and pathogenicity of Th17 cells. The regulation of these cytokine networks determines the intensity and duration of the Th17 response.
Metabolic and epigenetic control
In simple terms: How cells use energy and package their DNA affects whether they become Th17 cells.
The glucose transporter GLUT3 (SLC2A3) controls Th17 cell responses through glycolytic-epigenetic reprogramming, linking cellular metabolism to gene expression changes that favor Th17 differentiation. This metabolic checkpoint is a key node in the regulation of Th17 immunity and offers potential therapeutic targets.
MicroRNA-mediated regulation
In simple terms: Small RNA molecules fine-tune the balance between Th17 and regulatory T cells.
MicroRNAs regulate the Th17/Treg balance by targeting transcription factors, cytokines, and signaling molecules. Dysregulated microRNA networks contribute to autoimmune disease by shifting the balance toward Th17 or Treg phenotypes. This post-transcriptional layer is essential for maintaining immune homeostasis.
Th17/Treg balance and plasticity
In simple terms: The immune system must balance pro-inflammatory Th17 cells with anti-inflammatory Treg cells.
The relative abundance and function of Th17 versus regulatory T cells determine the outcome of immune responses. Alterations in this balance are associated with metabolic diseases and autoimmune conditions. Regulatory processes that modulate this balance are central to GO:2000316.
Key Genes Involved in GO:2000316 regulation of T-helper 17 type immune response
The following genes and proteins are central to the regulation of the Th17 immune response, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| RORC | Lineage-defining transcription factor for Th17 cells | Knockout or knockdown to block Th17 differentiation |
| IL17A | Signature effector cytokine of Th17 cells | Overexpression or knockout to study effector function |
| IL17F | Effector cytokine co-expressed with IL-17A | Models of mucosal immunity and autoimmunity |
| IL23R | Receptor for IL-23, essential for Th17 maintenance | Point mutations linked to inflammatory disease |
| IL6 | Cytokine that promotes Th17 differentiation | Knockout mice show impaired Th17 responses |
| TGFB1 | Cytokine involved in Th17 and Treg differentiation | Conditional knockout to dissect balance |
| STAT3 | Transcription factor downstream of IL-6 and IL-23 | Knockout or point mutation to study signaling |
| SLC2A3 | Glucose transporter GLUT3, controls Th17 metabolism | Knockout or overexpression to study glycolytic-epigenetic control |
| FOXP3 | Transcription factor for regulatory T cells | Knockout to assess Th17/Treg balance |
| MIR21 | MicroRNA regulating Th17/Treg balance | Overexpression or inhibition in autoimmune models |
| MIR155 | MicroRNA promoting Th17 differentiation | Knockout mice show altered Th17 responses |
| IL21 | Cytokine that amplifies Th17 responses | Overexpression or knockout in colitis models |
| IL22 | Effector cytokine acting on epithelial cells | Knockout to study mucosal immunity |
| CCR6 | Chemokine receptor guiding Th17 migration | Knockout or knock-in for tracking Th17 cells |
| IL1B | Cytokine that promotes Th17 pathogenicity | Knockout or overexpression in inflammatory models |
| TNF | Pro-inflammatory cytokine linked to Th17 responses | Knockout or humanized models |
| NLRP3 | Inflammasome component influencing Th17 responses | Knockout to study innate-adaptive crosstalk |
How Is regulation of T-helper 17 type immune response Regulated?
The regulation of the Th17 immune response is controlled at multiple levels. Cytokine signaling through IL-6, TGF-beta, IL-21, and IL-23 activates STAT3 and RORgamma-t, driving Th17 differentiation. Metabolic reprogramming via GLUT3 links glucose metabolism to epigenetic changes that sustain Th17 responses. MicroRNAs such as miR-21 and miR-155 fine-tune the Th17/Treg balance by targeting key transcription factors and signaling molecules. Additionally, autophagy and mitophagy pathways can influence immune cell survival and function, indirectly affecting Th17 responses. These layers of regulation ensure that Th17 immunity is appropriately balanced between protection and pathology.
regulation of T-helper 17 type immune response and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| IL17A | Periodontitis, psoriasis | Knockout mice or anti-IL-17 antibodies |
| IL23R | Inflammatory bowel disease | Knock-in of risk variants in mice |
| FOXP3 | Autoimmunity, IPEX syndrome | Knockout or point mutation mice |
| SLC2A3 | Th17-mediated inflammation | Conditional knockout in T cells |
| MIR21 | Autoimmune disease | Overexpression or antagomir treatment |
Th17 cells in autoimmune and inflammatory diseases
Dysregulated Th17 responses are central to the pathogenesis of several autoimmune and inflammatory diseases. In periodontitis, Th17 cells and their cytokines contribute to tissue destruction and chronic inflammation. In inflammatory bowel disease, including ulcerative colitis, the Th17/Treg balance is disrupted, and modulating this balance can alleviate disease in experimental models. The Th17/Treg balance is also altered in metabolic diseases such as obesity and type 2 diabetes, where it contributes to chronic low-grade inflammation.
MicroRNA-mediated regulation in autoimmunity
MicroRNAs play a critical role in regulating the Th17/Treg balance, and their dysregulation is associated with autoimmune diseases. For example, altered expression of specific microRNAs can shift the balance toward Th17, promoting inflammation. Targeting these microRNAs is a potential therapeutic strategy for restoring immune homeostasis.
Metabolic control of Th17 responses in disease
Metabolic reprogramming is increasingly recognized as a key regulator of Th17 pathogenicity. The glucose transporter GLUT3 controls Th17 responses through glycolytic-epigenetic reprogramming, and targeting this pathway may offer new therapeutic opportunities for Th17-mediated diseases.
Th17 responses in mucosal immunity and injury
Th17 cells are important for mucosal immunity, but their dysregulation can contribute to inflammatory conditions at barrier sites. Immune responses to injury, including in the eye, involve Th17 cells and their regulation. Understanding these processes can inform treatments for inflammatory eye diseases and other mucosal disorders.
From regulation of T-helper 17 type immune response-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X control Th17 differentiation? | Knockout of gene X in CD4+ T cells followed by Th17 polarization |
| Does a point mutation in gene Y alter Th17 function? | Knock-in of the mutation in mice or cell lines |
| Does overexpression of gene Z enhance Th17 responses? | Retroviral or transgenic overexpression in T cells |
| How does gene W affect Th17/Treg balance? | Knockout or knockdown followed by flow cytometry |
| Does a microRNA regulate Th17 responses? | Overexpression or inhibition of the microRNA in vivo |
| Can a drug target Th17 regulation? | Pharmacological inhibition in autoimmune models |
How to Study the regulation of T-helper 17 type immune response Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Flow cytometry | Th17 cell frequency and cytokine production | Phenotyping in autoimmune models |
| RNA-seq | Transcriptional changes during Th17 differentiation | Discovery of novel regulators |
| Seahorse assay | Glycolytic and oxidative metabolism | Metabolic control of Th17 cells |
| CRISPR screen | Genes affecting Th17 differentiation | Unbiased discovery of regulators |
| ELISA | Cytokine levels in supernatants | Quantifying IL-17 production |
| Western blot | Protein expression and signaling | Validating pathways |
| MicroRNA profiling | Expression of microRNAs | Identifying regulators of Th17/Treg balance |
| 16S rRNA sequencing | Gut microbiota composition | Linking microbiota to Th17 responses |
Flow cytometry and cytokine profiling
Flow cytometry is widely used to identify Th17 cells based on surface markers (e.g., CCR6) and intracellular cytokine staining for IL-17A, IL-17F, and IL-22. This method allows quantification of Th17 frequencies and functional status in various experimental conditions.
RNA sequencing and transcriptomics
RNA sequencing can reveal global gene expression changes during Th17 differentiation and activation. This approach helps identify novel regulators and pathways involved in GO:2000316, including transcription factors and microRNAs.
Metabolic assays
Seahorse extracellular flux analysis and glucose uptake assays measure metabolic activity, such as glycolysis, which is critical for Th17 differentiation. These methods link metabolic reprogramming to Th17 function.
CRISPR screening
Genome-wide CRISPR knockout or activation screens can identify genes that positively or negatively regulate Th17 differentiation. This unbiased approach accelerates discovery of new players in GO:2000316.
How CRISPR Can Be Used to Study GO:2000316 regulation of T-helper 17 type immune response
Knockout
CRISPR knockout of candidate genes in CD4+ T cells or cell lines can determine whether a gene is required for Th17 differentiation or function. For example, knocking out SLC2A3 (GLUT3) impairs Th17 responses, demonstrating its essential role.
Point Mutation
Introducing disease-associated point mutations (e.g., in IL23R or STAT3) using CRISPR can model human genetic variants and assess their impact on Th17 regulation. This approach helps establish causality between specific mutations and altered Th17 responses.
Knock-in
Knock-in of reporter genes (e.g., IL17A-GFP) or epitope tags allows tracking and isolation of Th17 cells in vivo. This facilitates detailed studies of Th17 dynamics and regulation.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression can increase expression of candidate genes to test whether they are sufficient to enhance or suppress Th17 responses. This is useful for studying microRNAs and transcription factors.
How EDITGENE Supports regulation of T-helper 17 type immune response Research
Researchers studying regulation of T-helper 17 type immune response-related genes often need to determine whether a candidate gene is causally involved in Th17 differentiation, function, or balance. EDITGENE provides comprehensive CRISPR-based services to enable such investigations with high precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for regulation of T-helper 17 type immune response research.
Frequently Asked Questions About regulation of T-helper 17 type immune response
What is GO:2000316?
GO:2000316 is a Gene Ontology term for regulation of T-helper 17 type immune response, describing any process that modulates the frequency, rate, or extent of Th17 immune responses.
What genes are involved in regulation of T-helper 17 type immune response?
Key genes include RORC, IL17A, IL23R, STAT3, FOXP3, and SLC2A3, among others.
How is Th17 immune response regulated?
It is regulated by cytokine signaling, transcription factors, metabolic reprogramming, and microRNAs that control Th17 differentiation and function.
What diseases are associated with Th17 dysregulation?
Th17 dysregulation is linked to autoimmune and inflammatory diseases such as periodontitis, inflammatory bowel disease, and metabolic disorders.
What is the Th17/Treg balance?
The Th17/Treg balance refers to the relative proportions and activities of pro-inflammatory Th17 cells and anti-inflammatory regulatory T cells, which is critical for immune homeostasis.
How can I study Th17 cells in the lab?
Common methods include flow cytometry, RNA-seq, metabolic assays, and CRISPR screens to identify regulators of Th17 differentiation.
What is the role of GLUT3 in Th17 cells?
GLUT3 (SLC2A3) controls Th17 responses through glycolytic-epigenetic reprogramming, linking metabolism to gene expression.
Which microRNAs regulate Th17 cells?
MicroRNAs such as miR-21 and miR-155 regulate the Th17/Treg balance and are implicated in autoimmune disease.
Can CRISPR be used to study Th17 regulation?
Yes, CRISPR knockout, knock-in, and activation screens are powerful tools to dissect gene function in Th17 biology.
What services does EDITGENE offer for Th17 research?
EDITGENE provides knockout, point mutation, knock-in, overexpression models, CRISPR library screening, and bioinformatics analysis for Th17 research.
Conclusion
GO:2000316, regulation of T-helper 17 type immune response, encompasses the complex molecular and cellular processes that control Th17 cell differentiation, function, and balance with regulatory T cells. This regulation is critical for protective immunity but also underlies numerous autoimmune and inflammatory diseases. Advances in CRISPR-based models and high-throughput screening are accelerating the discovery of new regulators and therapeutic targets. EDITGENE offers a comprehensive suite of services to support researchers in dissecting these mechanisms with precision and scale.
References
- 1. Xu Y et al.. 2020. Emerging views of mitophagy in immunity and autoimmune diseases.. Autophagy 16(1):3-17 PMID: 30951392
- 2. Stepp MA et al.. 2021. Immune responses to injury and their links to eye disease.. Transl Res 236:52-71 PMID: 34051364
- 3. Zhu X et al.. 2020. CD4 T Helper Cell Subsets and Related Human Immunological Disorders.. Int J Mol Sci 21(21) PMID: 33126494
- 4. Zhang S et al.. 2021. The Alterations in and the Role of the Th17/Treg Balance in Metabolic Diseases.. Front Immunol 12:678355 PMID: 34322117
- 5. Meyle J et al.. 2015. Molecular aspects of the pathogenesis of periodontitis.. Periodontol 2000 69(1):7-17 PMID: 26252398
- 6. Hochrein SM et al.. 2022. The glucose transporter GLUT3 controls T helper 17 cell responses through glycolytic-epigenetic reprogramming.. Cell Metab 34(4):516-532.e11 PMID: 35316657
- 7. Liu C et al.. 2018. MicroRNA-mediated regulation of T helper type 17/regulatory T-cell balance in autoimmune disease.. Immunology 155(4):427-434 PMID: 30133700
- 8. Tong L et al.. 2021. Milk-derived extracellular vesicles alleviate ulcerative colitis by regulating the gut immunity and reshaping the gut microbiota.. Theranostics 11(17):8570-8586 PMID: 34373759
